Clinical Trials Logo

Lateral Epicondylosis clinical trials

View clinical trials related to Lateral Epicondylosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT02596659 Completed - Clinical trials for Lateral Epicondylitis

Effectiveness of Radial Extracorporeal Shockwave Therapy on Tennis Elbow

Start date: September 2013
Phase: N/A
Study type: Interventional

Background: Tennis elbow, also known as lateral epicondylitis, is the inflammatory status of insertion site of common extensor tendon to humerus. It is usually related to overuse of local muscle. Radial extracorporeal shock wave therapy (rESWT) is a non-invasive physical treatment. It applies shockwave energy to the lesion site, enhancing the growth of microvascularity, inducing tissue repair, and thus relieving the symptom. The purpose of this study is to understand the therapeutic effect of rESWT to tennis elbow. Material and Methods - Subjects: 30 patients will be recruited from outpatient department of physical medicine and rehabilitation department. - Duration: 2013.09.01-2015.05.31 - Methods: The patients will be randomly divided into the experimental group and the control group through the draw, with 15 patients in each group. Patients in the experimental group receive rESWT plus routine rehabilitation program. Patients in the control group receive sham shockwave therapy plus routine rehabilitation program. - Assessment: Before the therapy starts, patients who match the inclusion criteria will be evaluated using tools mentioned below: - General data: age, sex, body height, body weight, affected side, medical history - Assess upper extremity function and symptom with Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH) - Assess severity of pain with Visual Analogue Scale (VAS) - Assess grip strength with grip strength dynamometer - Measure the size of tear (if any) of common extensor tendon through ultrasonography, and assess the texture of common extensor tendon through real-time sonoelastography (RTS) Patients will be followed up 6 weeks, 3months, and 6 months after therapy starts. They will be re-assessed of upper extremity function and symptom, severity of pain, grip strength, and presentation on ultrasonography and RTS.